Feminizing Treatment in Transgender Women and Non-binary Persons
NCT05169762 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-03-21
Summary
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Conditions
- Transgenderism
Interventions
- OTHER
-
standard treatment
starndard treatment for transgender women
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Dorte Glintborg · Odense University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-01
- Primary Completion
- 2035-09-01
- Completion
- 2035-09-01
Countries
- Denmark
Study Locations
More Related Trials
-
Extracellular Vesicles and Endothelial Function in Transgender Subjects
NCT04971447 ·Status: UNKNOWN ·Phase: NA
-
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
NCT06245681 ·Status: RECRUITING
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria
NCT06351501 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
NCT04128488 ·Status: COMPLETED
-
Prevention of Obesity in Women Via Estradiol Regulation
NCT00687739 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
NCT06969326 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
NCT04838249 ·Status: RECRUITING
-
Transgender Estradiol Affirming Therapy
NCT05010707 ·Status: COMPLETED ·Phase: PHASE2
-
A New Hormone Replacement Paradigm: Physiologic Restoration Study
NCT04190927 ·Status: UNKNOWN ·Phase: PHASE4
-
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
NCT01070979 ·Status: COMPLETED ·Phase: PHASE3
-
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men
NCT00740194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
NCT06291675 ·Status: RECRUITING
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
NCT04066283 ·Status: COMPLETED
-
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group
NCT00135148 ·Status: COMPLETED
-
Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years
NCT07315932 ·Status: RECRUITING
-
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
NCT04551144 ·Status: TERMINATED
-
Bioidentical Hormone Replacement Therapy in Postmenopausal Women
NCT07163442 ·Status: COMPLETED
-
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT05469204 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
NCT03856268 ·Status: WITHDRAWN
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Transdermal Estrogen in Women With Anorexia Nervosa
NCT03875378 ·Status: RECRUITING ·Phase: PHASE2
-
Progesterone in Gender Affirming Hormone Therapy Study
NCT06807580 ·Status: RECRUITING ·Phase: PHASE2
-
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
NCT03568708 ·Status: COMPLETED ·Phase: PHASE3